Ferrandina, Maria Gabriella
 Distribuzione geografica
Continente #
EU - Europa 8.345
NA - Nord America 8.122
AS - Asia 2.966
AF - Africa 70
SA - Sud America 43
Continente sconosciuto - Info sul continente non disponibili 21
OC - Oceania 11
Totale 19.578
Nazione #
US - Stati Uniti d'America 8.057
DE - Germania 2.494
SE - Svezia 1.648
CN - Cina 1.413
IT - Italia 967
SG - Singapore 800
UA - Ucraina 693
PL - Polonia 618
FR - Francia 500
IE - Irlanda 490
ID - Indonesia 297
GB - Regno Unito 285
RU - Federazione Russa 213
IN - India 187
FI - Finlandia 178
TR - Turchia 99
BE - Belgio 65
CA - Canada 51
CI - Costa d'Avorio 50
NL - Olanda 41
IR - Iran 39
JP - Giappone 34
HK - Hong Kong 26
CZ - Repubblica Ceca 19
ES - Italia 19
RO - Romania 19
BR - Brasile 16
EU - Europa 16
LT - Lituania 15
AT - Austria 14
CH - Svizzera 13
MX - Messico 10
AU - Australia 9
GR - Grecia 9
VN - Vietnam 9
DZ - Algeria 8
HR - Croazia 7
PH - Filippine 7
PK - Pakistan 7
AR - Argentina 6
BD - Bangladesh 6
CL - Cile 6
CO - Colombia 6
MT - Malta 6
AE - Emirati Arabi Uniti 5
NO - Norvegia 5
SA - Arabia Saudita 5
BG - Bulgaria 4
BH - Bahrain 4
IL - Israele 4
MD - Moldavia 4
MY - Malesia 4
PE - Perù 4
PT - Portogallo 4
A2 - ???statistics.table.value.countryCode.A2??? 3
EC - Ecuador 3
EG - Egitto 3
HU - Ungheria 3
KR - Corea 3
RS - Serbia 3
TW - Taiwan 3
A1 - Anonimo 2
BZ - Belize 2
DK - Danimarca 2
EE - Estonia 2
IQ - Iraq 2
JO - Giordania 2
LK - Sri Lanka 2
MA - Marocco 2
NZ - Nuova Zelanda 2
PA - Panama 2
QA - Qatar 2
TJ - Tagikistan 2
UG - Uganda 2
AL - Albania 1
CM - Camerun 1
ET - Etiopia 1
FK - Isole Falkland (Malvinas) 1
IS - Islanda 1
KE - Kenya 1
KW - Kuwait 1
KZ - Kazakistan 1
LV - Lettonia 1
MK - Macedonia 1
MO - Macao, regione amministrativa speciale della Cina 1
MU - Mauritius 1
OM - Oman 1
SC - Seychelles 1
SK - Slovacchia (Repubblica Slovacca) 1
VE - Venezuela 1
Totale 19.578
Città #
Chandler 1.886
Singapore 625
Ashburn 607
Warsaw 570
Dublin 475
Jacksonville 442
San Mateo 408
Wilmington 312
Jakarta 296
Nanjing 269
Hangzhou 236
New York 233
Ann Arbor 223
Beijing 197
Houston 191
Dearborn 177
Boston 163
Fairfield 158
Nürnberg 149
Rome 148
Moscow 141
Princeton 139
Woodbridge 139
Cattolica 138
Milan 136
Marseille 125
Lawrence 121
Seattle 107
Redwood City 104
Bremen 85
Nanchang 83
Izmir 75
Boardman 62
Brussels 61
Cambridge 61
Leawood 60
Lancaster 57
Zhengzhou 56
Los Angeles 55
University Park 54
Strasbourg 53
Mountain View 51
Abidjan 50
Munich 49
Kraków 47
Norwalk 47
Kunming 46
Detroit 42
Hebei 42
Redmond 41
Shenyang 41
Changsha 40
Jiaxing 38
Helsinki 36
Augusta 34
Andover 31
Tianjin 31
Chicago 30
Pune 29
Toronto 29
London 28
Fremont 27
Guangzhou 27
Shanghai 24
Hefei 19
San Jose 19
Frankfurt am Main 18
Edinburgh 17
Palermo 15
Simi Valley 15
Washington 15
Menlo Park 14
Vienna 14
Amsterdam 13
Busto Arsizio 13
Hong Kong 13
Jinan 13
Lanzhou 13
Phoenixville 12
Ardabil 11
Auburn Hills 11
Millbury 11
San Francisco 11
Wuhan 11
São Paulo 10
Berlin 9
Brno 9
Falls Church 9
Indiana 9
Ottawa 9
Santa Clara 9
Bologna 8
Kish 8
Naples 8
Perugia 8
Portland 8
Shenzhen 8
Timisoara 8
Bucchianico 7
Genazzano 7
Totale 10.949
Nome #
Clinical outcome of recurrent locally advanced cervical cancer (lacc) submitted to primary multimodality therapies 796
The MITO CERV-2 trial: A randomized phase II study of cetuximab plus carboplatin and paclitaxel, in advanced or recurrent cervical cancer 452
Metronomic oral cyclophosphamide (MOC) in the salvage therapy of heavily treated recurrent ovarian cancer patients: a retrospective, multicenter study 347
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 310
Carboplatin plus paclitaxel versus carboplatin plus pegylated liposomal doxorubicin as first-line treatment for patients with ovarian cancer: the MITO-2 randomized phase III trial 303
Clinical utility of trabectedin for the treatment of ovarian cancer: current evidence 252
Prognostic role of topoisomerase-IIalpha in advanced ovarian cancer patients 248
Evaluation of quality of life and emotional distress in endometrial cancer patients: A 2-year prospective, longitudinal study 187
I nuovi mezzi di contrasto nello studio delle patologie ginecologiche. Applicazioni diagnostiche e prospettive terapeutiche. 179
Paclitaxel, epirubicin, and cisplatin (TEP) regimen as neoadjuvant treatment in locally advanced cervical cancer: long-term results 176
Mammography before post-operative radiotherapy in conservatively managed breast cancer patients: is it useful? 168
Transvaginal ultrasonography and magnetic resonance imaging for assessment of presence, size and extent of invasive cervical cancer. 167
Long-term analysis of clinical outcome and complications in locally advanced cervical cancer patients administered concomitant chemoradiation followed by radical surgery 165
Laparoscopic staging of apparent early stage ovarian cancer: results of a large, retrospective, multi-institutional series 163
Quality of life and psychological distress in locally advanced cervical cancer patients administered pre-operative chemoradiotherapy 149
Adrenomedullin in Ovarian Cancer: Foe In Vitro and Friend In Vivo? 147
Chemoradiation with concomitant boosts followed by radical surgery in locally advanced cervical cancer: long-term results of the ROMA-2 prospective phase 2 study 147
Phase III trial of gemcitabine compared with pegylated liposomal doxorubicin in progressive or recurrent ovarian cancer. 140
Short-Course Accelerated Radiotherapy in Palliative Treatment of Advanced Pelvic Malignancies: A Phase I Study 138
Preoperative local staging of endometrial cancer: transvaginal sonography vs. magnetic resonance imaging. 137
Should laparoscopy be included in the work-up of advanced ovarian cancer patients attempting interval debulking surgery? 135
Sonographic imaging of urinoma 132
Prognostic role of Ca125 response criteria and RECIST criteria: analysis of results from the MITO-3 phase III trial of gemcitabine versus pegylated liposomal doxorubicin in recurrent ovarian cancer. 130
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience. 129
Volumetric intensity modulated arc therapy for stereotactic body radiosurgery in oligometastatic breast and gynecological cancers: feasibility and clinical results 128
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 126
Stereotactic radiosurgery (SRS) with volumetric modulated arc therapy (VMAT): interim results of a multi-arm phase I trial (DESTROY-2) 124
Impact of COVID-19 in gynecologic oncology: a Nationwide Italian Survey of the SIGO and MITO groups 123
Is frozen section analysis of pelvic lymph nodes accurate in locally advanced cervical cancer patients administered preoperative chemoradiation? 122
Ultrasound contrast examination to discriminate benign and malignant adnexal masses 121
A case of isolated ovarian recurrence from vulvar carcinoma. 120
Adjuvant volumetric-modulated arc therapy with simultaneous integrated boost in endometrial cancer. Planning and toxicity comparison 116
Phase III randomised clinical trial comparing primary surgery versus neoadjuvant chemotherapy in advanced epithelial ovarian cancer with high tumour load (SCORPION trial): Final analysis of peri-operative outcome. 116
Color Doppler sonographic features of a Krukenberg tumor in pregnancy 113
A complete pathological response to treatment in a young patient with locally advanced minimal deviation adenocarcinoma of the uterine cervix undergoing chemoradiation followed by radical surgery 111
Laparoscopic surgical management of localized recurrent ovarian cancer: a single-institution experience 110
Quality of life and emotional distress in early stage and locally advanced cervical cancer patients: a prospective, longitudinal study 109
Prognostic role of the recepteur d'origine nantais (RON) expression in ovarian cancer patients 105
Forward planned intensity modulated radiotherapy (IMRT) for whole breast postoperative radiotherapy. Is it useful? When? 104
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 104
Role of minimally invasive surgery versus open approach in patients with early-stage uterine carcinosarcomas: a retrospective multicentric study 103
Ultrasound evaluation of intra-abdominal sites of disease to predict the likelihood of suboptimal cytoreduction in advanced ovarian cancer: a propective study 101
Imaging in gynecological disease (1): ultrasound features of metastases in the ovaries differ depending on the origin of the primary tumor 100
Can radicality of surgery be safely modulated on the basis of MRI and PET/CT imaging in locally advanced cervical cancer patients administered preoperative treatment? 100
Extracranial radiosurgery with volumetric modulated arc therapy: Feasibility evaluation of a phase I trial 100
Preoperative local-regional staging of endometrial cancer: transvaginal sonography versus magnetic resonance imaging 98
Italian consensus conference on management of uterine sarcomas on behalf of S.I.G.O. (Societa' italiana di Ginecologia E Ostetricia) 97
Chemoradiation with concomitant boost followed by radical surgery in locally advanced cervical cancer: a dose-escalation study. 96
Concomitant boost dose escalation plus large-field preoperative chemoradiation in locally advanced carcinoma of the uterine cervix: results of a phase I study (LARA-CC-1). 96
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase ii study (ester-1). 96
Female pelvis 96
Phase I-II studies on accelerated IMRT in breast carcinoma: Technical comparison and acute toxicity in 332 patients. 96
Uterine inversion in association with uterine sarcoma: a case report with MRI findings and review of the literature 95
Evaluation of early regression index as response predictor in cervical cancer: A retrospective study on T2 and DWI MR images 94
Neuroendocrine stress response in patients undergoing benign ovarian cyst surgery by laparoscopy, minilaparotomy, and laparotomy 94
3D conformal postoperative radiotherapy with concomitant boost in uterine cancer: results of a phase I-II study (ADA-RT-1) 94
Stereotactic radiotherapy in recurrent gynecological cancer: a case series 93
The 'lead vessel': a vascular ultrasound feature of metastasis in the ovaries. 93
Clinical impact on ovarian cancer patients of massive parallel sequencing for BRCA mutation detection: the experience at Gemelli hospital and a literature review 92
Prospective multimodal imaging assessment of locally advanced cervical cancer patients administered by chemoradiation followed by radical surgery. The PRICE (PRospective Imaging of CErvical cancer and neoadjuvant treatment) study 2: the role of ultrasound after chemoradiation to assess residual tumor 90
Concomitant boost plus large-field preoperative chemoradiation in locally advanced uterine cervix carcinoma: Phase II clinical trial final results (LARA-CC-1) 89
Malignant transformation of Madelung's disease in a patient with a coincidental diagnosis of breast cancer: a case report. 89
Role of comorbidities in locally advanced cervical cancer patients administered preoperative chemoradiation: Impact on outcome and treatment-related complications. 88
Prolonged chemoradiation in locally advanced carcinoma of the uterine cervix: final results of a phase II study (ESTER-1). 86
Role of CT scan-based and clinical evaluation in the preoperative prediction of optimal cytoreduction in advanced ovarian cancer: a prospective trial 86
Survival after curative pelvic exenteration for primary or recurrent cervical cancer: a retrospective multicentric study of 167 patients. 86
Robotic Surgery in Elderly and Very Elderly Gynecologic Cancer Patients 86
Serous ovarian carcinoma recurring as a heterologous carcinosarcoma 85
Successful Treatment of a Young Patient with Locally Advanced Clear Cell Adenocarcinoma of the Uterine Cervix Undergoing Chemoradiation Followed by Radical Surgery 85
Prospective phase II trial of trabectedin in BRCA-mutated and/or BRCAness phenotype recurrent ovarian cancer patients: the MITO 15 trial 85
Neoadjuvant chemotherapy followed by conization in stage IB2–IIA1 cervical cancer larger than 2 cm: a pilot study 84
Successful multimodal treatment of a breast cancer patient with a recurrence invading the chest wall 83
Fertility-sparing surgery in ovarian cancer extended beyond the ovaries: a case report and review of the literature 83
Prognostic significance and clinical relevance of the expression of the HER family of type I receptor tyrosine kinases in human laryngeal squamous cell carcinoma 82
Active Breathing Coordinator in adjuvant three-dimensional conformal radiotherapy of early stage breast cancer: a feasibility study. 82
Long-term prospective longitudinal evaluation of emotional distress and quality of life in cervical cancer patients who remained disease-free 2-years from diagnosis 81
Epidermal growth factor levels in human breast cyst fluid 80
ASO Author Reflections: Conization Before Radical Hysterectomy Improves Disease-Free Survival in Early Stage Cervical Cancer 80
Intensity-modulated extended-field chemoradiation plus simultaneous integrated boost in the pre-operative treatment of locally advanced cervical cancer: a dose-escalation study 79
A Large, Multicenter, Retrospective Study on Efficacy and Safety Of Stereotactic Body Radiotherapy (SBRT) in Oligometastatic Ovarian Cancer (MITO RT1 Study): A Collaboration of MITO, AIRO GYN, and MaNGO Groups 79
How to Select Early-Stage Cervical Cancer Patients Still Suitable for Laparoscopic Radical Hysterectomy: a Propensity-Matched Study 79
A whole germline BRCA2 gene deletion: How to learn from CNV in silico analysis 78
Phase II study of the combination carboplatin plus celecoxib in heavily pre-treated recurrent ovarian cancer patients 77
Burkitt's lymphoma of the breast metastatic to the ovary diagnosed during pregnancy 77
Robotic Radical Hysterectomy After Concomitant Chemoradiation in Locally Advanced Cervical Cancer: A Prospective Phase II Study 77
Simultaneous Integrated Boost Volumetric Modulated Arc Therapy in the Postoperative Treatment of High-Risk to Intermediate-Risk Endometrial Cancer: Results of ADA II Phase 1-2 Trial 77
Long-term survival of young endometrial cancer patients desiring fertility preservation treated with hysteroscopic resection followed by hormone therapy (NEMO technique) 77
Epidermal growth factor levels in human breast cyst fluid 75
Estrogen Receptor Beta in Cancer: an Attractive Target for Therapy 75
Clinical outcome of recurrent locally advanced cervical cancer (LACC) submitted to primary multimodality therapies 75
Sonographic features of primary ovarian fibrosarcoma: a report of two cases. 73
Optimizing treatment in recurrent epithelial ovarian cancer 73
Fertility-sparing treatment in advanced-stage serous borderline ovarian tumors. An analysis from the MITO14 study database 73
Completion surgery after concomitant chemoradiation in locally advanced cervical cancer: a comprehensive analysis of pattern of postoperative complications 72
Carboplatin plus paclitaxel once a week versus every 3 weeks in patients with advanced ovarian cancer (MITO-7): a randomised, multicentre, open-label, phase 3 trial. 72
Impact of aromatase inhibitor treatment on vertebral morphology and bone mineral density in postmenopausal women with breast cancer 72
Postoperative treatment of intermediate-risk early stage cervical cancer: results of a survey from the Gynecology Study Group in the AIRO Gyn and MITO Groups 72
Ultrasound and color power Doppler in the detection of metastatic omentum: a prospective study 71
Prognostic significance and clinical relevance of the expression of the HER family of type I receptor tyrosine kinases in human laryngeal squamous cell carcinoma 71
L'ecografia tridimensionale in ginecologia: indicazioni, limiti e nuovi sviluppi in ginecologia. Working progress. 71
Totale 12.238
Categoria #
all - tutte 89.925
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 89.925


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/20201.908 0 0 0 0 175 266 346 173 252 162 283 251
2020/20212.242 141 199 87 238 299 102 266 64 208 182 363 93
2021/20222.589 285 157 47 257 122 68 46 407 108 192 390 510
2022/20235.190 694 712 411 785 345 631 225 387 628 138 156 78
2023/20242.476 100 729 67 157 74 320 178 87 47 98 319 300
2024/20251.309 134 136 397 187 455 0 0 0 0 0 0 0
Totale 20.826